VPAC targeted optical imaging assay (VPAC assay) of voided urine for management of patients with persistently elevated PSA
124 Background: Nearly 50% of patients with persistently elevated PSA (PEP) have prostate cancer (PCa) despite previous negative biopsy. However not all patients agree to undergo repeat, invasive trans rectal or trans perineal prostate biopsy (PB). To identify men at high risk of PCa, the need is un...
Saved in:
Published in | JCO global oncology Vol. 9; no. Supplement_1; p. 124 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.08.2023
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!